Ramon Bautista, MD
Neurology · Jacksonville, FLNPI 1750359956
Payments from drug & device makers
What this record shows
This record is dominated by education: $21 of the $21 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Eisai Inc.. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.
Across 1 payment — averaging $21.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$21
Across 19 payments — averaging $7800.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$116K
- SK Life Science, Inc.$32K
What the payments were for
- Education$21100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 1 | $21 |
How this compares
$21 in reported general payments places this provider in the 5th percentile of 1,434 neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 50 | $348,628 |
| TopamaxTopiramate | 40 | $58,968 |
| KeppraLevetiracetam | 19 | $54,821 |
| Oxtellar XrOxcarbazepine | 16 | $52,938 |
| Lacosamide | 224 | $45,089 |
| Rufinamide | 64 | $44,218 |
| VimpatLacosamide | 24 | $39,613 |
| Keppra XrLevetiracetam | 22 | $36,918 |
| TrileptalOxcarbazepine | 21 | $28,715 |
| LamictalLamotrigine | 20 | $26,918 |
| Lamictal XrLamotrigine | 12 | $24,616 |
| Levetiracetam | 441 | $22,859 |
| AptiomEslicarbazepine Acetate | 11 | $20,366 |
| Nurtec OdtRimegepant Sulfate | 13 | $20,331 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $16,756 |
Paid to pharmacies, not to this prescriber.
Other neurology in Jacksonville
- Steven ToenjesJacksonville$695K
- Zhigao HuangJacksonville$613K
- Kalina SandersJacksonville$544K
- Syed AsadJacksonville$302K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.